| 2023 |
| 12/19 | 12:00 当社子会社による英国Roslin Technologies LimitedとのiPS細胞作製技術に関するライセンス契約締結のお知らせ |
| 12/13 | 1,884 | 1,898 | 1,867 | 1,891 | +0.37% | 47,300 | 233億3184万 | -3.52% |
| 12/12 | 1,926 | 1,929 | 1,879 | 1,884 | -1.77% | 68,800 | 232億4547万 | -3.98% |
| 12/11 | 1,947 | 1,953 | 1,914 | 1,918 | -1.84% | 77,000 | 236億6498万 | -1.99% |
| 12/08 | 1,961 | 1,975 | 1,942 | 1,954 | -0.76% | 49,000 | 241億916万 | +0.21% |
| 12/07 | 12:30 2024年3月期(第27期)第2四半期決算説明資料 |
| 12/07 | 1,982 | 2,001 | 1,967 | 1,969 | -1.45% | 34,400 | 242億9424万 | +1.49% |
| 12/06 | 1,989 | 2,003 | 1,983 | 1,998 | +0.71% | 29,100 | 246億5205万 | +3.52% |
| 12/05 | 1,995 | 2,029 | 1,984 | 1,984 | -1.34% | 43,800 | 244億7931万 | +3.44% |
| 12/04 | 1,991 | 2,025 | 1,991 | 2,011 | +1.06% | 37,400 | 248億1245万 | +5.45% |
| 12/01 | 2,031 | 2,031 | 1,986 | 1,990 | -2.02% | 71,400 | 245億5334万 | +5.07% |
| 11/30 | 2,012 | 2,043 | 2,012 | 2,031 | +0.45% | 68,200 | 250億5921万 | +7.92% |
| 11/29 | 10:00 NTTコミュニケーションズ株式会社との協業に関するお知らせ |
| 11/29 | 1,963 | 2,040 | 1,963 | 2,022 | +2.9% | 282,600 | 249億4817万 | +8.3% |
| 11/28 | 1,936 | 1,965 | 1,933 | 1,965 | +1.5% | 50,500 | 242億4488万 | +6.1% |
| 11/27 | 1,942 | 1,953 | 1,926 | 1,936 | +0.05% | 26,700 | 238億8707万 | +5.22% |
| 11/24 | 1,938 | 1,962 | 1,935 | 1,935 | +0.21% | 38,500 | 238億7473万 | +5.74% |
| 11/22 | 1,952 | 1,955 | 1,930 | 1,931 | -0.57% | 75,200 | 238億2538万 | +6.04% |
| 11/21 | 1,919 | 1,949 | 1,914 | 1,942 | +1.04% | 45,000 | 239億6110万 | +7.17% |
| 11/20 | 1,928 | 1,945 | 1,920 | 1,922 | -0.31% | 51,800 | 237億1433万 | +6.6% |
| 11/17 | 1,950 | 1,987 | 1,914 | 1,928 | -1.63% | 85,800 | 237億8836万 | +7.29% |
| 11/16 | 1,957 | 1,969 | 1,941 | 1,960 | +0.15% | 53,100 | 241億8319万 | +9.38% |
| 11/15 | 1,970 | 1,970 | 1,925 | 1,957 | +0.93% | 104,300 | 241億4618万 | +9.64% |
| 11/14 | 1,972 | 1,972 | 1,936 | 1,939 | -1.22% | 51,300 | 239億2408万 | +8.99% |
| 11/13 | 2,003 | 2,003 | 1,949 | 1,963 | -2% | 74,800 | 242億2021万 | +10.78% |
| 11/10 | 2,004 | 2,011 | 1,963 | 2,003 | -0.55% | 97,900 | 247億1374万 | +13.48% |
| 11/09 | 1,951 | 2,015 | 1,950 | 2,014 | +2.49% | 220,800 | 248億4946万 | +14.76% |
| 11/08 | 1,938 | 1,971 | 1,918 | 1,965 | +1.34% | 184,400 | 242億4488万 | +12.41% |
| 11/07 | 1,817 | 1,948 | 1,816 | 1,939 | +11.63% | 527,000 | 239億2408万 | +11.24% |
| 11/06 | 15:30 剰余金の配当(中間配当)および期末配当予想の修正(増配)に関するお知らせ |
| 11/06 | 15:30 2024年3月期第2四半期決算短信〔日本基準〕(連結) |
| 11/06 | 1,760 | 1,771 | 1,729 | 1,737 | -0.74% | 81,800 | 214億3174万 | -0.23% |
| 11/02 | 1,735 | 1,754 | 1,722 | 1,750 | +1.86% | 68,200 | 215億9213万 | +0.11% |
| 11/01 | 1,734 | 1,746 | 1,715 | 1,718 | +0.17% | 35,700 | 211億9731万 | -2.11% |
| 10/31 | 1,689 | 1,723 | 1,686 | 1,715 | +1.24% | 51,000 | 211億6029万 | -2.67% |
| 10/30 | 1,703 | 1,712 | 1,676 | 1,694 | -1.4% | 107,700 | 209億119万 | -4.24% |
| 10/27 | 1,688 | 1,719 | 1,686 | 1,718 | +2.51% | 41,300 | 211億9731万 | -3.27% |
| 10/26 | 1,674 | 1,688 | 1,670 | 1,676 | -0.48% | 30,300 | 206億7909万 | -5.95% |
| 10/25 | 1,677 | 1,695 | 1,671 | 1,684 | +0.66% | 28,400 | 207億7780万 | -5.97% |
| 10/24 | 1,648 | 1,676 | 1,602 | 1,673 | +2.14% | 59,800 | 206億4208万 | -7.06% |
| 10/23 | 1,648 | 1,658 | 1,629 | 1,638 | -1.44% | 68,500 | 202億1024万 | -9.45% |
| 10/20 | 1,663 | 1,673 | 1,635 | 1,662 | -0.89% | 60,800 | 205億636万 | -8.68% |
| 10/19 | 1,699 | 1,705 | 1,677 | 1,677 | -2.39% | 51,900 | 206億9143万 | -8.41% |
| 10/18 | 1,712 | 1,718 | 1,680 | 1,718 | +1.24% | 75,100 | 211億9731万 | -6.63% |
| 10/17 | 1,724 | 1,742 | 1,693 | 1,697 | -1.79% | 123,400 | 209億3820万 | -8.12% |
| 10/16 | 9:05 COVID-19ワクチン「IRO-203」開発の進捗報告 |
| 10/16 | 1,759 | 1,760 | 1,723 | 1,728 | -1.99% | 53,700 | 213億2069万 | -6.8% |
| 10/13 | 1,793 | 1,793 | 1,762 | 1,763 | -2.16% | 39,500 | 217億5253万 | -5.16% |
| 10/12 | 1,798 | 1,808 | 1,783 | 1,802 | +0.45% | 21,000 | 222億3373万 | -3.33% |
| 10/11 | 1,798 | 1,800 | 1,780 | 1,794 | -0.22% | 35,500 | 221億3502万 | -3.86% |
| 10/10 | 1,804 | 1,816 | 1,792 | 1,798 | +1.24% | 33,200 | 221億8438万 | -3.7% |
| 10/06 | 1,795 | 1,795 | 1,776 | 1,776 | -1.06% | 22,300 | 219億1293万 | -4.98% |
| 10/05 | 1,795 | 1,805 | 1,769 | 1,795 | +2.28% | 59,400 | 221億4736万 | -4.06% |
| 10/04 | 1,789 | 1,798 | 1,753 | 1,755 | -3.36% | 76,300 | 216億5383万 | -6.25% |
| 10/03 | 1,851 | 1,860 | 1,812 | 1,816 | -2% | 56,100 | 224億647万 | -3.2% |
| 10/02 | 1,891 | 1,907 | 1,853 | 1,853 | -2.47% | 39,700 | 228億6299万 | -1.23% |
| 09/29 | 1,919 | 1,919 | 1,882 | 1,900 | -0.52% | 28,600 | 234億4289万 | +1.33% |
| 09/28 | 1,902 | 1,925 | 1,900 | 1,910 | -0.57% | 40,900 | 235億6627万 | +2.08% |
| 09/27 | 1,902 | 1,921 | 1,888 | 1,921 | +1.64% | 47,300 | 237億199万 | +2.84% |
| 09/26 | 1,892 | 1,900 | 1,882 | 1,890 | -0.11% | 23,000 | 233億1950万 | +1.39% |
| 09/25 | 1,868 | 1,897 | 1,868 | 1,892 | +1.23% | 20,500 | 233億4418万 | +1.67% |
| 09/22 | 1,840 | 1,882 | 1,831 | 1,869 | +0.65% | 39,000 | 230億6040万 | +0.75% |
| 09/21 | 1,906 | 1,910 | 1,857 | 1,857 | -2.77% | 57,300 | 229億1234万 | +0.43% |
| 09/20 | 1,890 | 1,931 | 1,890 | 1,910 | +0.21% | 93,900 | 235億6627万 | +3.52% |
| 09/19 | 1,907 | 1,917 | 1,891 | 1,906 | -0.05% | 68,100 | 235億1692万 | +3.53% |
| 09/15 | 1,913 | 1,919 | 1,896 | 1,907 | -0.42% | 47,900 | 235億2926万 | +3.81% |
| 09/14 | 1,925 | 1,925 | 1,901 | 1,915 | -0.26% | 31,900 | 236億2796万 | +4.47% |
| 09/13 | 12:00 (開示事項の経過)当社子会社による独Evotec社との臨床用iPS細胞作製技術のライセンス契約に関するお知らせ |
| 09/13 | 1,894 | 1,926 | 1,894 | 1,920 | +0.63% | 56,400 | 236億8966万 | +5.09% |
| 09/12 | 1,897 | 1,917 | 1,891 | 1,908 | +1.27% | 55,300 | 235億4160万 | +4.72% |
| 09/11 | 1,889 | 1,893 | 1,867 | 1,884 | +0.27% | 35,700 | 232億4547万 | +3.63% |
| 09/08 | 1,875 | 1,888 | 1,870 | 1,879 | +0.75% | 52,900 | 231億8378万 | +3.53% |
| 09/07 | 1,866 | 1,886 | 1,857 | 1,865 | -0.32% | 44,000 | 230億1105万 | +2.81% |
| 09/06 | 1,853 | 1,876 | 1,853 | 1,871 | +1.03% | 47,000 | 230億8508万 | +3.14% |
| 09/05 | 1,839 | 1,854 | 1,829 | 1,852 | +0.98% | 49,600 | 228億5065万 | +2.04% |
| 09/04 | 1,840 | 1,846 | 1,827 | 1,834 | -0.11% | 24,700 | 226億2856万 | +0.94% |
| 09/01 | 1,814 | 1,837 | 1,814 | 1,836 | +0.82% | 31,600 | 226億5323万 | +0.82% |
| 08/31 | 1,834 | 1,846 | 1,811 | 1,821 | -0.6% | 59,100 | 224億6816万 | -0.22% |
| 08/30 | 1,850 | 1,854 | 1,830 | 1,832 | -0.65% | 40,200 | 226億388万 | +0.11% |
| 08/29 | 1,845 | 1,863 | 1,837 | 1,844 | +1.04% | 63,500 | 227億5194万 | +0.55% |
| 08/28 | 1,847 | 1,849 | 1,818 | 1,825 | -0.16% | 45,300 | 225億1751万 | -0.71% |
| 08/25 | 1,805 | 1,846 | 1,795 | 1,828 | +0.99% | 66,200 | 225億5453万 | -0.76% |
| 08/24 | 1,825 | 1,832 | 1,810 | 1,810 | -0.82% | 32,900 | 223億3244万 | -1.95% |
| 08/23 | 1,825 | 1,836 | 1,812 | 1,825 | 0% | 36,800 | 225億1751万 | -1.4% |
| 08/22 | 12:00 (開示事項の経過)当社子会社による京都大学iPS細胞研究財団(iPS財団)とのセンダイiPSの使用条件に関する覚書締結のお知らせ |
| 08/22 | 1,822 | 1,832 | 1,806 | 1,825 | +0.66% | 51,000 | 225億1751万 | -1.62% |
| 08/21 | 1,739 | 1,823 | 1,739 | 1,813 | +4.38% | 140,600 | 223億6945万 | -2.42% |
| 08/18 | 1,702 | 1,744 | 1,693 | 1,737 | +1.16% | 95,800 | 214億3174万 | -6.71% |
| 08/17 | 1,755 | 1,755 | 1,713 | 1,717 | -2.44% | 164,600 | 211億8497万 | -8.13% |
| 08/16 | 1,798 | 1,799 | 1,758 | 1,760 | -2.44% | 100,100 | 217億1552万 | -6.23% |
| 08/15 | 1,817 | 1,828 | 1,800 | 1,804 | -0.11% | 87,800 | 222億5841万 | -4.25% |
| 08/14 | 1,812 | 1,825 | 1,802 | 1,806 | +0.17% | 50,900 | 222億8308万 | -4.44% |
| 08/10 | 1,768 | 1,812 | 1,763 | 1,803 | +1.69% | 79,100 | 222億4607万 | -4.85% |
| 08/09 | 1,782 | 1,812 | 1,773 | 1,773 | -1.12% | 109,200 | 218億7592万 | -6.78% |
| 08/08 | 1,813 | 1,856 | 1,793 | 1,793 | -1.05% | 204,700 | 221億2268万 | -6.17% |
| 08/07 | 15:30 株式会社ワールドスキャンプロジェクトとのMedical web3時代のウェルビーイング実現に向けた戦略的パートナーシップ契約締結のお知らせ |
| 08/07 | 1,726 | 1,815 | 1,726 | 1,812 | -0.44% | 236,200 | 223億5711万 | -5.53% |
| 08/04 | 15:30 2024年3月期第1四半期決算短信〔日本基準〕(連結) |
| 08/04 | 1,815 | 1,828 | 1,792 | 1,820 | -0.66% | 124,900 | 224億5582万 | -5.41% |
| 08/03 | 1,860 | 1,862 | 1,832 | 1,832 | -1.82% | 74,100 | 226億388万 | -5.08% |
| 08/02 | 1,900 | 1,905 | 1,858 | 1,866 | -2.15% | 113,700 | 230億2338万 | -3.52% |
| 08/01 | 1,900 | 1,921 | 1,891 | 1,907 | -0.05% | 82,200 | 235億2926万 | -1.55% |
| 07/31 | 1,939 | 1,943 | 1,907 | 1,908 | -0.68% | 70,400 | 235億4160万 | -1.65% |
| 07/28 | 1,920 | 1,930 | 1,898 | 1,921 | -1.18% | 68,400 | 237億199万 | -1.08% |
| 07/27 | 1,944 | 1,953 | 1,903 | 1,944 | +0.15% | 75,100 | 239億8578万 | 0% |
| 07/26 | 1,925 | 1,945 | 1,923 | 1,941 | +0.31% | 19,100 | 239億4876万 | -0.21% |
| 07/25 | 1,949 | 1,949 | 1,930 | 1,935 | -0.31% | 28,500 | 238億7473万 | -0.57% |
| 07/24 | 1,935 | 1,953 | 1,930 | 1,941 | +0.73% | 58,800 | 239億4876万 | -0.31% |
| 07/21 | 1,919 | 1,936 | 1,917 | 1,927 | +0.1% | 21,400 | 237億7602万 | -1.03% |
| 07/20 | 1,926 | 1,940 | 1,920 | 1,925 | -0.52% | 21,000 | 237億5135万 | -1.03% |
